GPIMEDIUM SIGNALFINANCIAL10-K

GPI experienced a significant decline in net income despite revenue growth, driven by substantially higher operating expenses and increased debt levels.

The 35% drop in net income while gross profit grew 12% indicates meaningful margin compression, likely from the 17% increase in SG&A expenses outpacing revenue gains. The $700M increase in total debt alongside share count reduction of over 1.3 million shares suggests active capital allocation through buybacks funded by borrowing, which may pressure future earnings if not managed carefully.

Comparing 2026-02-13 vs 2025-02-14View on EDGAR →
FINANCIAL ANALYSIS

GPI's financial profile shows mixed signals with gross profit growing modestly by 12% while net income fell meaningfully by 35%, reflecting operational efficiency challenges. The substantial increase in SG&A expenses more than offset revenue gains, compressing margins significantly. Despite earnings pressure, operating cash flow improved 19% and total debt increased 26%, suggesting the company is actively managing capital structure while facing near-term profitability headwinds.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-34.7%
$498.1M$325.2M

Net income declined 34.7% — review whether driven by operations, interest costs, or non-recurring items.

Total Debt
Balance Sheet
+25.7%
$2.7B$3.4B

Debt rose 25.7% — additional borrowing for investment or operations; monitor coverage ratios.

Operating Income
P&L
-19.3%
$909.1M$734.0M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Operating Cash Flow
Cash Flow
+18.5%
$586.3M$694.5M

Operating cash flow grew 18.5% — strong conversion of earnings to cash, healthy business fundamentals.

SG&A Expense
P&L
+16.8%
$2.2B$2.5B

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Gross Profit
P&L
+11.7%
$3.2B$3.6B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

LANGUAGE CHANGES
NEW — 2026-02-13
PRIOR — 2025-02-14
ADDED
As of February 6, 2026, there were 11,925,199 shares of our common stock, par value $0.01 per share, outstanding.
Market for Registrant Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 26 Item 6.
These forward-looking statements include, but are not limited to, statements concerning the Company s strategy, future operating performance, future supply constraints, future liquidity and availability of financing, capital allocation, the completion of future acquisitions and divestitures, as well as the impact of cyberattacks or other privacy/data security incidents, business trends in the retail automotive industry, changes to regulations and policies applicable to our operations, including battery EV mandates in the U.K.
and their impact on new vehicle demand and potential changes in U.S.
and global trade policy, including the imposition by the U.S.
+7 more — sign up free →
REMOVED
As of February 7, 2025 , there were 13,244,315 shares of our common stock, par value $0.01 per share, outstanding.
Market for Registrant Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 25 Item 7.
These forward-looking statements include, but are not limited to, statements concerning the Company s strategy, future operating performance, future liquidity and availability of financing, capital allocation, the completion of future acquisitions and divestitures, as well as the impact of cyberattacks or other privacy/data security incidents, business trends in the retail automotive industry, changes in regulations and potential changes in U.S.
trade policy, including the imposition of tariffs and the resulting consequences.
As of December 31, 2024, our retail network consists of 145 dealerships and 27 collision centers in the U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →